AIM ImmunoTech Inc (AIM)

Sep 30, 2025

Why AIM ImmunoTech Inc. stock remains top rated2025 Trade Ideas & Free AI Powered Buy and Sell Recommendations - newser.com

Sep 30, 2025

Sep 30, 2025

Will AIM ImmunoTech Inc. (HXB) stock benefit from Fed rate cutsJuly 2025 Closing Moves & High Accuracy Swing Entry Alerts - newser.com

Sep 30, 2025

Sep 30, 2025

Will AIM ImmunoTech Inc. stock keep raising dividendsJuly 2025 News Drivers & Safe Entry Trade Signal Reports - newser.com

Sep 30, 2025

Sep 30, 2025

Can AIM ImmunoTech Inc. (HXB) stock sustain breakout momentumWeekly Risk Report & Free Verified High Yield Trade Plans - newser.com

Sep 30, 2025

Sep 30, 2025

How AIM ImmunoTech Inc. (HXB) stock compares with top peersTrade Entry Summary & Long-Term Safe Investment Ideas - newser.com

Sep 30, 2025

Sep 30, 2025

Can AIM ImmunoTech Inc. (HXB) stock hit consensus price targetsProfit Target & Advanced Swing Trade Entry Alerts - newser.com

Sep 30, 2025

Sep 29, 2025

How AIM ImmunoTech Inc. stock stacks up against competitorsTrade Performance Summary & Verified Swing Trading Watchlists - newser.com

Sep 29, 2025

Sep 29, 2025

How AIM ImmunoTech Inc. (HXB) stock performs in volatility spikesMarket Risk Analysis & Reliable Price Action Trade Plans - newser.com

Sep 29, 2025

Sep 25, 2025

AIM ImmunoTech Secures Patent in Japan Through 2039 for - GlobeNewswire

Sep 25, 2025

Sep 25, 2025

AIM ImmunoTech Secures Japan Patent for Ampligen in Cancer Treat - GuruFocus

Sep 25, 2025

Sep 25, 2025

AIM ImmunoTech Secures Patent in Japan Through 2039 for Novel Cancer Therapy Combining Ampligen® (Rintatolimod) with Checkpoint Inhibitors - The Manila Times

Sep 25, 2025

Sep 25, 2025

Novel Cancer Therapy Patent Victory: AIM ImmunoTech's Ampligen Combo Shows Promise in Phase 2 Trials - Stock Titan

Sep 25, 2025

Sep 24, 2025

Analyzing AIM ImmunoTech (NYSE:AIM) and ZIVO Bioscience (NASDAQ:ZIVO) - Defense World

Sep 24, 2025

Sep 23, 2025

AIM ImmunoTech Announces Publication of Journal Article On - GlobeNewswire

Sep 23, 2025

Sep 22, 2025

AIM ImmunoTech's Ampligen Shows Promise in Cancer Treatment - GuruFocus

Sep 22, 2025

Sep 22, 2025

Breakthrough Cancer Treatment: AIM ImmunoTech's Ampligen + Interferon Shows Promise Against 'Cold' Tumors - Stock Titan

Sep 22, 2025

Sep 21, 2025

Maxim Group Sees 133% Upside in AIM ImmunoTech Inc. (AIM) - Insider Monkey

Sep 21, 2025